ENDPOINTS

Ginkgo uncertain over the future of US government funding, stock drops

Ginkgo Bioworks’ stock $DNA fell by around 13% premarket Wednesday after the company dampened its 2025 sales forecast. “We are being conservative with our revenue guidance in 2025 given uncertainty around ...

Feb 26, 2025 - 13:40
 0
Ginkgo uncertain over the future of US government funding, stock drops
Ginkgo Bioworks’ stock $DNA fell by around 13% premarket Wednesday after the company dampened its 2025 sales forecast. “We are being conservative with our revenue guidance in 2025 given uncertainty around ...
Read More

Tags:

Previous Article

Finally, a pair of digital binoculars that’ll make you feel like Doctor Who

Next Article

What are cancer vaccines?

Related Posts

Updates from Washington; A trio of Big Pharma deals; What do recent share buybacks mean for M&A?; and more

Updates from Washington; A trio of Big Pharma deals; Wh...

Feb 15, 2025  0

Government is set to address its lab-developed test rule in court

Government is set to address its lab-developed test rul...

Feb 19, 2025  0

FDA won’t allow Invivyd’s Pemgarda to treat Covid; Antibiotic biotech launches

FDA won’t allow Invivyd’s Pemgarda to treat Covid; Anti...

Feb 24, 2025  0